SLC35G2: A Promising Drug Target and Biomarker for Diseases (G80723)

Target Name: SLC35G2

NCBI ID: G80723

SLC35G2

SLC35G2: A Promising Drug Target and Biomarker for Diseases

SLC35G2, also known as SLC35G2 gene, is a member of the Absolute Carrier Family 35 and its variant 1 transcript. It is a gene that encodes a protein known as solute carrier family 35 member G2 (SC35G2). SC35G2 is a protein that is expressed in various tissues and cells of the body, including the brain, heart, and kidneys. It plays a crucial role in the transport of different solutes and ions across cell membranes, which is essential for maintaining the proper functioning of various physiological processes in the body.

SLC35G2 is a promising drug target and has been identified as a potential biomarker for various diseases. Its role in the transport of ions and solutes across cell membranes makes it an attractive target for drug development due to its potential impact on various physiological processes.

One of the key advantages of SLC35G2 as a drug target is its high expression level in different tissues and cells. This means that targeting the SLC35G2 gene has the potential to be effective in treating a wide range of diseases. Additionally, the SLC35G2 gene is well - conserved across different species, which indicates that it is a reliable and robust target for drug development.

SLC35G2 has also been shown to be involved in various physiological processes in the body. For example, studies have shown that SLC35G2 is involved in the regulation of ion and solute transport in the brain, which is important for maintaining cognitive function and the development of various neurological conditions. Additionally, SLC35G2 has been shown to be involved in the regulation of ion and solute transport in the heart, which is important for maintaining heart health and the development of various cardiovascular conditions.

Another promising aspect of SLC35G2 as a drug target is its potential to serve as a biomarker for various diseases. The ability of SLC35G2 to be expressed in different tissues and cells makes it a potential marker for various diseases, including those related to neurodegenerative disorders, diabetes , and hypertension. Additionally, the consistency of SLC35G2 expression across different species makes it a potential biomarker for disease progression and treatment outcomes.

In conclusion, SLC35G2 is a promising drug target and has the potential to be effective in treating a wide range of diseases. Its high expression level in different tissues and cells, as well as its involvement in various physiological processes in the body, makes it an attractive target for drug development. Additionally, SLC35G2 has been shown to be involved in the regulation of ion and solute transport in various tissues, which makes it a potential biomarker for diseases. Further research is needed to fully understand the role of SLC35G2 as a drug target and its potential as a biomarker for various diseases.

Protein Name: Solute Carrier Family 35 Member G2

Functions: May play a role in cell proliferation

The "SLC35G2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC35G2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets